DatasetName,NUP155_S(1057) NUP155_S(486) NUP155_S(5) NUP155_S(914) NUP155_S(994),NUP155_S(1128) NUP155_S(3) NUP155_S(4) NUP155_S(928) NUP155_S(930) NUP155_S(933) NUP155_S(987) NUP155_S(992)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,0.5521179637628969
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.5483985388886922
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5544765580936951
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5552821131534418
HS2024_6_B_T3,,0.5709341607587971
JW2015_Intensity pre1,,0.560184570736052
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5623432306139416
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.5547822292362891
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.5598274894711128
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,0.570286719172389
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5476277986302264
WZ2023_Pu_010_30min,,0.5797415346331571
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5735042640592898
RB2022_8_RecoveryEndurance,,0.5483762493996033
KBE2022_Log2_Ex_14_U,,0.5501489672809793
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.4394669637882528,0.5535436752905376
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.5714569973648432
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.5673221800253557
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.5405494895676818
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5606010091166743
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.5622620419649844
GF2025_P6_Sph,,0.5583433225383797
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5557501582548529
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.5794632554866487
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.560022793555062
KBE2022_Log2_Ex_34_U,,0.5540306726836699
WZ2023_Pu_005_10min,,0.5779625872141909
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5632477783035474
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5698769669830082
WZ2023_Pu_025_30min,,0.5797967991047175
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,,0.570924916625942
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.5410729831895403
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5664988079220414
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5668342784915247
HS2024_7_PD_T2,,0.5680727282775196
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,0.5624533095843087
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.552548740773303
HS2024_3_B_N1,,0.5678019725762106
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.577930525494565
CK2022_11 40-1,,0.5628805906852197
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.563894564274515
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.42502919505751285,0.5926580673838528
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,,0.5800170269149424
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.5461036939935713
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.5683531510013211
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5686812244140145
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.5422332101652217
HS2024_9_B_T2,,0.5952799140940488
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.5611716484701633
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.5467922679511593
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.5515786888445664
CK2022_1 200-1,,0.567656730374481
PG2020_Intensity Mock_10h_D,,0.5597676805519844
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.5661695701721975
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5612278341125515
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.5381553460567583
PG2020_Intensity 2h_C,,0.5567922412482625
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.55439545563751
KBE2022_Log2_Ex_8_T,,0.5502356212394934
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,0.5724724755433326
RN2012_L11,0.43002514686129373,0.5521294204651827
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,0.5478005231018567
AH2018_LFQ_M_2_C,,0.5603882464749816
CK2022_3 40-1,,0.5606832187403393
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.5538185515839855
YA2020_Reporter_intensity_Cancer_No.5,,0.5628219149397122
HH2022_Reporter intensity 8,,
ZQ2022_N2,,0.5394457359528538
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5410205733300165
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.5822912115507162
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5660695033179266
YA2020_Reporter_intensity_Normal_No.1,,0.554687091839392
HS2024_3_B_T1,,0.5522392234110874
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.5560007473462908
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.560066195247405
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5537242193315389
HS2024_8_I_T3,,0.5551250636626475
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.5762110790572126
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,0.5810487804961612
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5606660313764503
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.5484261640266045
KS2014_Intensity N3,0.44902324832578655,0.5888919606775392
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5550366861807612
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.558131884741574
HS2024_8_PD_T1,,0.5379617841975354
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.43550367911163557,0.5924771861950161
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5624619673263799
HS2024_7_I_T1,,0.5531869120865793
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.5288199679864413
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.5539349844548751
AH2018_SILAC_M_3_X,,0.5666870047860765
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.5482401644432127
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5592089228524774
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.5579091756383816
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.5475850836902796
HS2024_6_B_N1,,0.5668513639380985
KBE2022_Log2_Ex_27_T,,0.5611161086892159
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.43729546972615474,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5693843676181816
AH2018_SILAC_IT_3_X,,0.5648465724368559
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.5700381097988089
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,0.5468489810851449
CK2022_14 40-1,,0.5613552469042932
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5676469167400797
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.5634116701443446
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5676830828244248
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5626237862880894
EJN2021_4_Rest_Ins,,
RN2012_H05,0.450873620829524,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5410589213931192
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,0.567109259923082
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5483873400210267
JW2021_After_3,,0.5676351400414239
GF2025_P8_Sph,,0.5632242039802372
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5646242717576626
CK2022_11 200-1,,0.5708084827447859
CK2022_12 200-1,,0.5725460411419477
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.5542016132164814
WZ2023_Su_010_20min,,0.5795040141238943
AH2018_TMTMS2_2_N,0.43793449990070743,0.5564158203994719
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5550351832043717
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.4376573630213498,
AH2018_TMTMS3_Pool,,0.54581757857241
KS2014_Intensity N4,0.45241478060574697,0.5921002226571781
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.5669468500703828
CK2022_14 200-1,,0.5697657253467427
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.5429018936808679
AST2020_anti-CD3+PDL2.2,,0.5592744365891742
PG2020_Intensity Mock_10h_A,,0.5578440219535157
JW2021_After_2,,0.5700487439252578
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.5514989789126886
GF2025_P1_Adh,,0.5354084609513199
GF2025_P1_Sph,,0.5658052469789643
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,0.5569535882747413
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.579292621506588
CF2017_EOC 1,,0.5765169212427227
CK2022_3 200-1,,0.5682378136647794
AH2018_LFQ_IT_3_C,,0.5674005434048051
SR2019_Hs578T_Biol_repl_2,,0.5077143602638776
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,0.5644095996975116
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.5576011356282009
HS2024_5_B_T1,,0.5571562001135989
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.5470455878970054
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5600113703513245
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5670909963986891
JW2021_Before_2,,0.554027984479716
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.5485335104209224
AR2021_ALG 1 μM,,0.5679956225473859
HS2024_4_B_T1,,0.5440089059603165
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,0.5458646711768298
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5509134675083013
CK2022_9 16-1,,0.5546337147973853
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.5710532143057232
CK2022_13 200-1,,0.5693190605337686
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.5727959291409801
CK2022_16 16-1,,0.5559336559434982
FS2019_db/db3,,
CK2022_15 40-1,,0.5618243034630283
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.5776161555505355
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5645488726866578
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5637550059389294
HS2024_5_PD_T3,,0.5535092278347639
AH2018_TMTMS3_3_X,,0.552532978513719
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.5512823483757053
AH2018_LFQ_M_1_N,,0.5695197785535807
KBE2022_Log2_Ex_27_U,,0.5620043927566485
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5559771204832442
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.5742019768791438
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.5598088283404338
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5611151963792331
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.5573524776066694
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.5534681573575926
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.5655355654892945
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.5488593186377234
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5624838443277917
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5707477930918764
HH2022_Reporter intensity 6,,0.5557486408455125
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5404594154708834
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.4452505380504084,0.5544512592601946
GF2025_P3_Adh,,0.5471223863103665
SR2019_JIMT1_Biol_repl_2,,0.541103038430184
AH2018_TMTMS2_1_C,0.44106296459712124,0.5630652922638444
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5744557685652831
KBE2022_Log2_Ex_19_U,,0.5546761492139382
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5614243575447571
AST2020_Control,,0.5606999182992664
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,0.5863885140354209
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.5663031932678466
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,0.5378923816656148
YA2020_Reporter_intensity_Normal_No.3,,0.558464865750483
HS2024_8_B_T2,,0.5669814328208409
AH2018_LFQ_1_X,,0.5676173675683367
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.44873184043450554,0.5974152235743801
HH2022_Reporter intensity 1,,0.5664831674893155
HH2022_Reporter intensity 2,,0.5667977290343145
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5569241619956435
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.5660820736365246
SR2019_LM2_Biol_repl_3,,0.51841691793529
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5537201066385795
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,,0.5556524339074282
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.5564363327953812
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5585839877972874
KBE2022_Log2_Ex_9_U,,0.5525971320711288
AH2018_SILAC_M_3_N,,0.5663571489889135
KBE2022_Log2_Ex_13_T,,0.5526236328164206
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,0.5173981958374569
PG2020_Intensity Mock_10h_C,,0.5575894810387079
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,0.5540859356299538
PG2020_Intensity 10h_A,,0.5578474580794135
RN2012_L12,0.43067152348974025,0.5523196305965415
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.565596408072631
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,0.5607885451009826
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5594787569099178
RB2022_7_RecoveryEndurance,,0.545979216461709
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,0.5543207054189091
KS2014_Intensity pY_PV3,,0.5482891317942705
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.563338053849186
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.5581062347357416
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.41595094906768776,0.5810147196198102
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.5313637678379902
CK2022_7 200-1,,0.5657986645049216
CK2022_5 200-1,,0.5667203405620953
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.5533466384331408
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.5554237894092525
AH2018_SILAC_3_C,,0.5656044960533392
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,0.5501121311848284
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,0.5486205895369378
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5643978098788582
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.5616534760285546
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,0.5636290437068149
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.5647461507096155
KBE2022_Log2_Ex_9_T,,0.5565655154003849
AH2018_SILAC_IT_2_N,,0.5631963965405757
AH2018_SILAC_IT_1_X,,0.5677220866354888
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.5579155092841358
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5533344981870713
WZ2023_Pe_025_20min,,0.5783087998884233
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5670730173052085
HS2024_4_I_N2,,0.5474484666559338
AH2018_TMTMS2_3_N,0.4415243871610359,0.556282458196795
RN2012_H06,,0.554594129389695
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.5636583828947794
WZ2023_Su_005_30min,,0.5770032798779268
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5488586994810708
WZ2023_Su_025_10min,,0.5781495155876645
AH2018_LFQ_IT_4_X,,0.5664829549007739
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.5782793324181554
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.5724677008566394
EP2017_Pervanadate R#1 log2 ratio,,0.5598303648911167
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4628896436783722,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5667798762725773
LY2019_P7+,,0.5860766556224084
EP2017_Untreated R#1 normalized log2 ratio,,0.5629356297861712
RN2012_L10,0.4199701281000035,0.5209426028008824
PG2020_Intensity 4h_C,,0.5651666794676021
EP2017_Mitotic R#3 normalized log2 ratio,,0.5610563963871616
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.5583611911558507
RB2022_8_PostStrength,,0.5465049935002553
AH2018_SILAC_IT_2_X,,0.563826183546425
HS2024_4_B_T3,,0.5618787237616045
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.5617828724305318
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.573342407714325
KBE2022_Log2_Ex_6_U,,0.5572484402833136
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5469205085740771
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5702934176329854
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.5632355050432104
GF2025_P9_Sph,,0.5584345194884062
CK2022_6 200-1,,0.5657515729912441
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.563648716470812
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,0.5611906674984761
SR2019_HCC1954_Biol_repl_1,,0.5512162415531219
HS2024_4_I_T2,,0.5577615041607525
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.5526525598029092
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,0.5743476839411593
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.5602976871169494
EP2017_Untreated R#3 normalized log2 ratio,,0.5553568592376736
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5660628639036231
KS2014_Intensity pY_C4,,0.5559925966202499
CR2017_Ratio Replicate 3.5,,0.5464128429278214
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5625311798205609
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5675193622150089
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.5567704658276136
KBE2022_Log2_Ex_29_T,,0.5520919301415209
HS2024_7_I_T2,,0.5679113702245113
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.5685225804950715
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,0.5606504828919486
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.5514235113421898
KBE2022_Log2_Ex_39_U,,0.5507816380204049
EP2017_Untreated R#3 log2 ratio,,0.5552208152157505
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5602120009961334
HS2024_8_PD_T2,,0.5580677759355068
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.5634542449641156
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5697456239753008
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.5568448349490512
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5381307057215312
YA2020_Reporter_intensity_Normal_No.2,,0.5554021842231028
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.5534535585588571
HS2024_3_PD_T3,,0.5466264246448879
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5729816147561146
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.5549543224940958
CK2022_2 16-1,,0.549681848162538
RAM2015_Log2 B,,0.555632752590418
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.5710912051718076
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,0.5571147567338552
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.5470553715261283
PG2020_Intensity Mock_10h_B,,0.5576619994210246
WZ2023_Su_025_30min,,0.5801505895195495
AH2018_LFQ_4_N,,0.56249829681712
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.5635950378682868
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5506504050889901
AH2018_SILAC_M_1_X,,0.5560354378249004
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5610480646537013
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5823437228674989
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.5356149605341052
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.550607082372064
SR2019_Hs578T_Biol_repl_4,,0.5248702303440885
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.43980723080917583,0.5905856113726561
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5760724714864762
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.5603463269846543
SR2019_BT549_Biol_repl_1,,0.5306144974945655
AH2018_LFQ_M_4_N,,0.5688016518595196
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5674452874989441
AH2018_LFQ_2_X,,0.5488710225323321
PG2020_Intensity 2h_B,,0.5589342039349777
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4441826647537793,0.5922093981859333
GF2025_P3_Sph,,0.5592359180169924
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5545002322945871
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5625484217133653
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5550377242173902
ZQ2022_N1,,0.5383424410264901
LY2019_P6-,,0.5342303530470219
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,0.5591187880562547
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5632839816215904
AH2018_LFQ_3_N,,0.5653070600522876
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.5549585275759252
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.5598359114719956
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.565508326048237
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.5369379230446296
WZ2023_Su_025_20min,,0.5766349360750739
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5814510379027101
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5615878318890153
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.43942787547895634,0.5496455706562108
PG2020_Intensity 10h_D,,0.5636513998218247
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,0.5631703354135578
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,,0.560896839505733
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,0.5697967930789267
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.4492042659935379,
CK2022_6 40-1,,0.5585537938821765
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.5658133934071528
LY2019_P3-,,0.5816363053406438
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.580542962025708
HS2024_8_PD_T3,,0.5460442534959674
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,0.5585432084310372
JW2015_Intensity cap1,,0.5625934874720753
PG2020_Intensity CT_A,,0.5510922973676871
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,0.5797208486526625
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5508088741870644
RB2022_1_RecoveryStrength,,0.5700073701661544
SR2019_HCC1954_Biol_repl_4,,0.5487554955050438
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,0.5544423576355157
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.4322822350074419,0.5557211748431997
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5523108541321913
HS2024_8_I_N2,,0.5684143593346705
RB2022_3_RecoveryStrength,,0.5651305433856804
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5574398562576969
LY2019_P8+,,0.5784311992492799
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5543619226690308
KS2014_Intensity pY_PV1,,0.5591190297128656
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.44576815001024694,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5657151589464182
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.5513285600262253
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.5757283484725411
LY2019_P2-,,0.540413905297075
AH2018_LFQ_IT_1_X,,0.5550901889214335
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.5659622690650519
WZ2023_Pe_005_20min,,0.5801372533240605
AST2020_Control.2,,0.5599472752976066
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.5559532733786815
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5597957074756665
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,0.5548603823500308
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.5538670759213709
HS2024_5_B_T2,,0.5602238087610658
HS2024_6_I_T1,,0.5737465053615163
HS2024_5_B_T3,,0.5415546217188594
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.5621053452337649
AH2018_TMTMS3_3_N,,0.5542707799809772
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.5620747919492115
KBE2022_Log2_Ex_36_T,,0.5599892268436852
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.5799544923588582
KS2014_Intensity C2,0.41538025598892786,0.5797258800041469
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.5584435640998009
CK2022_9 200-1,,0.570537894063781
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.569763478406889
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.5513139801793245
RBK2021_1332T Late,,
LY2019_P1-,,0.5255209589355673
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.559014948072657
HS2024_3_I_T3,,0.5521838176941254
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.41421417842055525,0.5954127619628642
ZQ2022_C3,,0.5690536886190172
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.5492136715606568
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.5628028790457409
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.5779584321679413
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,0.5504950527260475
KS2014_Intensity N1,0.45258072124298254,0.5949517678354115
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.5450767805623108
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.5544703713585213
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.42681792799476376,0.5529730354604507
HS2024_5_B_N2,,0.5599020933961953
HS2024_5_I_N1,,0.5578721867789264
HS2024_6_I_N1,,0.557548925201829
AR2021_KD 48h,,0.5391051350833455
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,0.558504146937537
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,0.5108267255064186
AST2020_anti-CD3,,0.5613739146151492
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.5790246900176885
KBE2022_Log2_Ex_29_U,,0.5512824526488225
HS2024_7_B_T1,,0.5640191001437671
AH2018_LFQ_M_2_X,,0.557573378493906
AH2018_LFQ_IT_4_N,,0.5660579460274557
CK2022_15 200-1,,0.5703983257262499
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.5598551009598935
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.5675464289016235
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.5678430943094303
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.5803691113936674
RN2012_H01,0.45149471223862064,0.5518947588638643
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5595153876071741
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5629888512540201
KBE2022_Log2_Ex_44_U,,0.5541465724522101
WZ2023_Pe_010_20min,,0.5811896730089842
KS2014_Intensity pY_C6,,0.5551904386369242
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.4303383046472482,0.5826314337193224
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,0.5658806197954271
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5692799473257925
AH2018_SILAC_M_2_X,,0.5633514973470213
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.5594386057578378
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.5796125423921019
PG2020_Intensity 6h_C,,0.5698057183025531
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5714848205610367
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.4372827362718577,0.5593922776035134
CK2022_15 16-1,,0.5543005591350798
CK2022_3 16-1,,0.5501517455678192
LY2019_P4-,,0.5300880376777475
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,0.5506643459352047
HS2024_3_I_N2,,0.5770927161428421
GF2025_P8_Adh,,0.5599339906078605
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5683960460017673
CK2022_10 16-1,,0.5532964690018598
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.4285216177354684,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.5638682000427224
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5689085686811126
AR2021_L41 10 μM,,0.568611779673024
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5550569373210891
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.5561955738893873
CK2022_6 16-1,,0.5494334059707147
ZX2022_CB treated Replicate 1,,0.5547930872550896
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.4397471748546695,0.5609035902248334
AR2021_L41 1 μM,,0.5720260595967906
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.43854028057510525,0.5548659474802761
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5552184690598847
KS2014_Intensity C4,,0.5901279230755032
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.5500628757274069
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,0.5392556946387069
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.57140365218189
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5628107245434941
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.5461820540487491
WZ2023_Pu_025_10min,,0.5784265078304719
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,0.5441864353641592
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.5696954246448729
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.5810645872084803
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5644809506478015
KS2014_Intensity C6,0.4143975587097546,0.5841029190249273
ZQ2022_N3,,0.5367846411851301
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5651780231993595
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5562760301729625
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5618010770471074
AH2018_SILAC_IT_2_C,,0.5456699328848706
CK2022_5 40-1,,0.5596764910515861
AH2018_LFQ_3_X,,0.5602852413630824
UK2020_UA_3,,
LY2019_P7-,,0.5305721606711958
GF2025_P5_Adh,,0.5400944696612846
RB2022_1_PostStrength,,0.5806284067356423
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,0.5448177689055631
CR2017_Ratio Replicate 2.2,,0.560424113210452
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.5524303075876376
ZQ2022_C1,,0.5699773127294494
CR2017_Ratio Replicate 2.1,,0.559996633920949
PG2020_Intensity CT_B,,0.5595729402628928
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,0.5515164852980423
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5651317006241251
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.566670576109657
YA2020_Reporter_intensity_Cancer_No.4,,0.5622910491670172
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5711998236144726
RB2022_2_PreEndurance,,
JW2021_Before_1,,0.5541334181464409
KBE2022_Log2_Ex_25_T,,0.5574890984396299
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.5547078952224584
AST2020_anti-CD3+PDL2,,0.5610323801050763
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.574941038665525
KS2014_Intensity pY_N1,,0.5672345099771866
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,0.5578151801353121
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.5618284420916244
AH2018_TMTMS2_1_X,0.4419195718990484,0.5584080898579185
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,0.5635175795095189
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,0.5744149747687575
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,0.5534624597268031
AH2018_SILAC_1_X,,0.5551384723871907
PG2020_Intensity 10h_B,,0.5645160088960924
AH2018_TMTMS3_1_X,,0.5334125650695607
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5705162637346959
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.55651650712357
EP2017_Untreated R#2 normalized log2 ratio,,0.5661941642297716
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5309524338007962
HS2024_5_I_N2,,0.5491693834441426
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.562831464619107
AS2011_Ratio H/L Normalized RNAi_2_1,,
